Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current Assets
Cash	$ 2,746,555	$ 3,325,131
Advances on research and development contract services	208,972	258,059
Prepaid insurance	196,533	268,179
Prepaid expenses	10,000	10,000
Total current assets	3,162,060	3,861,369
Total assets	3,162,060	3,861,369
Current Liabilities
Accounts payable and accrued expenses	247,843	373,042
Warrant liability	3,315	4,670
Total current liabilities	251,158	377,712
Total liabilities	251,158	377,712
Commitments and Contingencies
Preferred Stock, $0.001 par value per share; 20,000,000 shares authorized; none issued or outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.001 par value per share; 100,000,000 shares authorized; 3,271,042 and 2,953,982 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	3,270	2,953
Additional paid-in capital	88,946,102	88,502,082
Accumulated deficit	(86,038,470)	(85,021,378)
Total stockholders’ equity	2,910,902	3,483,657
Total liabilities and stockholders’ equity	$ 3,162,060	$ 3,861,369